BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34328643)

  • 41. Functional analysis of ESM1 by siRNA knockdown in primary and metastatic head and neck cancer cells.
    Bender O; Gunduz M; Cigdem S; Hatipoglu OF; Acar M; Kaya M; Grenman R; Gunduz E; Ugur KS
    J Oral Pathol Med; 2018 Jan; 47(1):40-47. PubMed ID: 29024069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CDH11 inhibits proliferation and invasion in head and neck cancer.
    Piao S; Inglehart RC; Scanlon CS; Russo N; Banerjee R; D'Silva NJ
    J Oral Pathol Med; 2017 Feb; 46(2):89-97. PubMed ID: 27397103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
    Sun Z; Li S; Kaufmann AM; Albers AE
    Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long Noncoding RNA LINC00460 Promotes Cell Progression by Sponging miR-4443 in Head and Neck Squamous Cell Carcinoma.
    Li M; Zhang X; Ding X; Zheng Y; Du H; Li H; Ji H; Wang Z; Jiao P; Song X; Zhong Y; Wu H
    Cell Transplant; 2020; 29():963689720927405. PubMed ID: 32478564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
    Schröck A; Bode M; Göke FJ; Bareiss PM; Schairer R; Wang H; Weichert W; Franzen A; Kirsten R; van Bremen T; Queisser A; Kristiansen G; Heasley L; Bootz F; Lengerke C; Perner S
    Carcinogenesis; 2014 Jul; 35(7):1636-42. PubMed ID: 24743512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
    Nohata N; Hanazawa T; Kinoshita T; Inamine A; Kikkawa N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2013 Apr; 108(8):1648-58. PubMed ID: 23558898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.
    Rao VH; Kandel A; Lynch D; Pena Z; Marwaha N; Deng C; Watson P; Hansen LA
    Oncogene; 2012 Jun; 31(23):2888-98. PubMed ID: 21986939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer.
    Jerhammar F; Johansson AC; Ceder R; Welander J; Jansson A; Grafström RC; Söderkvist P; Roberg K
    Oral Oncol; 2014 Sep; 50(9):832-9. PubMed ID: 24993889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. S100A11 is a migration-related protein in laryngeal squamous cell carcinoma.
    Wang C; Zhang Z; Li L; Zhang J; Wang J; Fan J; Jiao B; Zhao S
    Int J Med Sci; 2013; 10(11):1552-9. PubMed ID: 24046531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
    Li P; Bian XY; Chen Q; Yao XF; Wang XD; Zhang WC; Tao YJ; Jin R; Zhang L
    PLoS One; 2017; 12(5):e0177484. PubMed ID: 28494008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
    Cao W; Zhang ZY; Xu Q; Sun Q; Yan M; Zhang J; Zhang P; Han ZG; Chen WT
    Mol Cancer; 2010 Nov; 9():296. PubMed ID: 21092172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma.
    Gerster K; Shi W; Ng B; Yue S; Ito E; Waldron J; Gilbert R; Liu FF
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):253-60. PubMed ID: 20394857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knockdown of β-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines.
    Chang HW; Lee YS; Nam HY; Han MW; Kim HJ; Moon SY; Jeon H; Park JJ; Carey TE; Chang SE; Kim SW; Kim SY
    Cell Signal; 2013 Apr; 25(4):839-47. PubMed ID: 23280187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Feed-Forward Regulatory Loop between HuR and the Long Noncoding RNA HOTAIR Promotes Head and Neck Squamous Cell Carcinoma Progression and Metastasis.
    Xu CZ; Jiang C; Wu Q; Liu L; Yan X; Shi R
    Cell Physiol Biochem; 2016; 40(5):1039-1051. PubMed ID: 27941336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stabilization of Slug by NF-κB is Essential for TNF-α -Induced Migration and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cells.
    Liu S; Shi L; Wang Y; Ye D; Ju H; Ma H; Yang W; Wang Y; Hu J; Deng J; Zhang Z
    Cell Physiol Biochem; 2018; 47(2):567-578. PubMed ID: 29794474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA alterations in head and neck squamous cell carcinoma.
    Chang SS; Jiang WW; Smith I; Poeta LM; Begum S; Glazer C; Shan S; Westra W; Sidransky D; Califano JA
    Int J Cancer; 2008 Dec; 123(12):2791-7. PubMed ID: 18798260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B; Zhu J; Meng L
    Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.